{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T04:29:01Z","timestamp":1786768141140,"version":"build-2736575974"},"reference-count":28,"publisher":"Japanese Society of Internal Medicine","issue":"16","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026,8,15]]},"DOI":"10.2169\/internalmedicine.6030-25","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T22:08:14Z","timestamp":1768428494000},"page":"2250-2255","source":"Crossref","is-referenced-by-count":0,"title":["Parkinsonism in Idiopathic Normal Pressure Hydrocephalus or Hydrocephalic Presentation in Parkinson's Disease: A Report of Three Cases"],"prefix":"10.2169","volume":"65","author":[{"given":"Rei","family":"Yoshihama","sequence":"first","affiliation":[{"name":"Department of Neurology and Neurological Science, Institute of Science Tokyo, Japan"},{"name":"Department of Neurology, Nissan Tamagawa Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Ohara","sequence":"additional","affiliation":[{"name":"Department of Neurology and Neurological Science, Institute of Science Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taiki","family":"Matsubayashi","sequence":"additional","affiliation":[{"name":"Department of Neurology and Neurological Science, Institute of Science Tokyo, Japan"},{"name":"National Hospital Organization Disaster Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaaki","family":"Hattori","sequence":"additional","affiliation":[{"name":"Department of Neurology and Neurological Science, Institute of Science Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Adams RD, Fisher CM, Hakim S, Ojemann RG, Sweet WH. Symptomatic occult hydrocephalus with &quot;normal&quot; cerebrospinal-fluid pressure. A treatable syndrome. N Engl J Med 273: 117-126, 1965.","DOI":"10.1056\/NEJM196507152730301"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Mostile G, Fasano A, Zappia M. Parkinsonism in idiopathic normal pressure hydrocephalus: is it time for defining a clinical tetrad? Neurol Sci 43: 5201-5205, 2022.","DOI":"10.1007\/s10072-022-06119-3"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Espay AJ, Da Prat GA, Dwivedi AK, et al. Deconstructing normal pressure hydrocephalus: ventriculomegaly as early sign of neurodegeneration. Ann Neurol 82: 503-513, 2017.","DOI":"10.1002\/ana.25046"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson&apos;s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55: 181-184, 1992.","DOI":"10.1136\/jnnp.55.3.181"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Curran T, Lang AE. Parkinsonian syndromes associated with hydrocephalus: case reports, a review of the literature, and pathophysiological hypotheses. Mov Disord 9: 508-520, 1994.","DOI":"10.1002\/mds.870090503"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Magdalinou NK, Ling H, Smith JD, Schott JM, Watkins LD, Lees AJ. Normal pressure hydrocephalus or progressive supranuclear palsy? A clinicopathological case series. J Neurol 260: 1009-1013, 2013.","DOI":"10.1007\/s00415-012-6745-6"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Sakurai A, Tsunemi T, Shimada T, et al. Effect of comorbid Parkinson&apos;s disease and Parkinson&apos;s disease dementia on the course of idiopathic normal pressure hydrocephalus. J Neurosurg 137: 1302-1309, 2022.","DOI":"10.3171\/2022.1.JNS212282"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Hashimoto M, Ishikawa M, Mori E, Kuwana N; The study of INPH on neurological improvement (SINPHONI). Diagnosis of idiopathic normal pressure hydrocephalus is supported by MRI-based scheme: a prospective cohort study. Cerebrospinal Fluid Res 7: 18, 2010.","DOI":"10.1186\/1743-8454-7-18"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Ohara M, Hirata K, Hallett M, et al. Long-term levodopa ameliorates sequence effect in simple, but not complex walking in early Parkinson&apos;s disease patients. Parkinsonism Relat Disord 108: 105322, 2023.","DOI":"10.1016\/j.parkreldis.2023.105322"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Ohara M, Hattori T, Chen Q, et al. Is there a spinal tap responder in progressive supranuclear palsy? The first prospective study. J Neurol 271: 4473-4484, 2024.","DOI":"10.1007\/s00415-024-12391-4"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Matsuda H, Murata M, Mukai Y, et al. Japanese multicenter database of healthy controls for [<sup>123<\/sup>I]FP-CIT SPECT. Eur J Nucl Med Mol Imaging 45: 1405-1416, 2018.","DOI":"10.1007\/s00259-018-3976-5"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Postuma RB, Berg D, Stern M, et al. MDS clinical diagnostic criteria for Parkinson&apos;s disease. Mov Disord 30: 1591-1601, 2015.","DOI":"10.1002\/mds.26424"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Nakajima M, Yamada S, Miyajima M, et al.; The research committee of idiopathic normal pressure hydrocephalus. Guidelines for management of idiopathic normal pressure hydrocephalus (third edition): endorsed by the Japanese Society of Normal Pressure Hydrocephalus. Neurol Med Chir (Tokyo) 61: 63-97, 2021.","DOI":"10.2176\/nmc.st.2020-0292"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Todisco M, Zangaglia R, Minafra B, et al. Clinical outcome and striatal dopaminergic function after shunt surgery in patients with idiopathic normal pressure hydrocephalus. Neurology 96: e2861-e2873, 2021.","DOI":"10.1212\/WNL.0000000000012064"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Nishida Y, Yokota T. Reversible reduction of dopamine transporter uptake in a case of hydrocephalus. Ann Neurol 90: 326-327, 2021.","DOI":"10.1002\/ana.26130"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Tateno F, Sakakibara R, Kishi M, et al. Sensitivity and specificity of metaiodobenzylguanidine (MIBG) myocardial accumulation in the diagnosis of Lewy body diseases in a movement disorder clinic. Parkinsonism Relat Disord 17: 395-397, 2011.","DOI":"10.1016\/j.parkreldis.2011.02.001"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Kawazoe M, Arima H, Maeda T, et al. Sensitivity and specificity of cardiac <sup>123<\/sup>I-MIBG scintigraphy for diagnosis of early-phase Parkinson&apos;s disease. J Neurol Sci 407: 116409, 2019.","DOI":"10.1016\/j.jns.2019.07.027"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Zhang Y, Zhang C, He XZ, et al. Interaction between the glymphatic system and \u03b1-synuclein in Parkinson&apos;s disease. Mol Neurobiol 60: 2209-2222, 2023.","DOI":"10.1007\/s12035-023-03212-2"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Zou W, Pu T, Feng W, et al. Blocking meningeal lymphatic drainage aggravates Parkinson&apos;s disease-like pathology in mice overexpressing mutated \u03b1-synuclein. Transl Neurodegener 8: 7, 2019.","DOI":"10.1186\/s40035-019-0147-y"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Ding XB, Wang XX, Xia DH, et al. Impaired meningeal lymphatic drainage in patients with idiopathic Parkinson&apos;s disease. Nat Med 27: 411-418, 2021.","DOI":"10.1038\/s41591-020-01198-1"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Ringstad G, Vatnehol SAS, Eide PK. Glymphatic MRI in idiopathic normal pressure hydrocephalus. Brain 140: 2691-2705, 2017.","DOI":"10.1093\/brain\/awx191"},{"key":"22","doi-asserted-by":"crossref","first-page":"e121537","DOI":"10.1172\/jci.insight.121537","volume":"3","author":"G Ringstad","year":"2018","unstructured":"22. Ringstad G, Valnes LM, Dale AM, et al. Brain-wide glymphatic enhancement and clearance in humans assessed with MRI. JCI Insight 3: e121537, 2018.","journal-title":"JCI Insight","ISSN":"https:\/\/id.crossref.org\/issn\/2379-3708","issn-type":"print"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Eide PK, Ringstad G. Delayed clearance of cerebrospinal fluid tracer from entorhinal cortex in idiopathic normal pressure hydrocephalus: a glymphatic magnetic resonance imaging study. J Cereb Blood Flow Metab 39: 1355-1368, 2019.","DOI":"10.1177\/0271678X18760974"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Ohara M, Hattori T. The glymphatic system in cerebrospinal fluid dynamics: clinical implications, its evaluation, and application to therapeutics. Neurodegener Dis 189-201, 2025.","DOI":"10.1159\/000546286"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Broggi M, Redaelli V, Tringali G, et al. Normal pressure hydrocephalus and parkinsonism: preliminary data on neurosurgical and neurological treatment. World Neurosurg 90: 348-356, 2016.","DOI":"10.1016\/j.wneu.2016.03.004"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Nagayama H, Hamamoto M, Ueda M, Nagashima J, Katayama Y. Reliability of MIBG myocardial scintigraphy in the diagnosis of Parkinson&apos;s disease. J Neurol Neurosurg Psychiatry 76: 249-251, 2005.","DOI":"10.1136\/jnnp.2004.037028"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Ohara M, Hattori T, Yokota T. Progressive supranuclear palsy often develops idiopathic normal pressure hydrocephalus-like magnetic resonance imaging features. Eur J Neurol 27: 1930-1936, 2020.","DOI":"10.1111\/ene.14322"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Williams DR, de Silva R, Paviour DC, et al. Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson&apos;s syndrome and PSP-parkinsonism. Brain 128: 1247-1258, 2005.","DOI":"10.1093\/brain\/awh488"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/16\/65_6030-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T04:11:32Z","timestamp":1786767092000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/16\/65_6030-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,15]]},"references-count":28,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.6030-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,15]]},"article-number":"6030-25"}}